Ahmet Cingöz

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Oncogene

Neurological research

Cell death & disease

Koç University

Koç Üniversitesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Koç University Aug 01 2019

Turkey

Post-doctoral Researcher :: KUTTAM-School of Medicine

Education History

Koç Üniversitesi Sep 01 2014 - Jun 24 2019

Turkey

PHD :: School of Medicine

Marmara University

Turkey

MSC :: School of Medicine

Istanbul University Sep 09 2005

Turkey

BSC :: Biology

Publications

Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova, Fidan Seker-Polat, Myvizhi Esai Selvan, Zeynep Hülya Gümüş, Deepak Bhere, Khalid Shah, Ihsan Solaroglu, Tugba Bagcı-Önder
Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene 43 (34) (2024)
Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova, Fidan Seker-Polat, Myvizhi Esai Selvan, Zeynep Hülya Gümüş, Deepak Bhere, Khalid Shah, Ihsan Solaroglu, Tugba Bagcı-Önder
Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene (2024)
Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova, Fidan Seker-Polat, Myvizhi Esai Selvan, Zeynep Hülya Gümüş, Deepak Bhere, Khalid Shah, Ihsan Solaroglu, Tugba Bagcı-Önder
Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene 43 (34) (2024)
Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova, Fidan Seker-Polat, Myvizhi Esai Selvan, Zeynep Hülya Gümüş, Deepak Bhere, Khalid Shah, Ihsan Solaroglu, Tugba Bagcı-Önder
Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene 40 (18) (2021)
Ilknur Sur-Erdem, Kerem Muslu, Nareg Pınarbası, Mine Altunbek, Fidan Seker-Polat, Ahmet Cingöz, Serdar Onur Aydin, Mehmet Kahraman, Mustafa Culha, Ihsan Solaroglu, Tugba Bagcı-Önder
TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway. Neurological research 42 (12) (2020)
Ezgi Ozyerli-Goknar, Ilknur Sur-Erdem, Fidan Seker, Ahmet Cingöz, Alisan Kayabolen, Zeynep Kahya-Yesil, Fırat Uyulur, Melike Gezen, Nazife Tolay, Batu Erman, Mehmet Gönen, James E Dunford, Udo Oppermann, Tugba Bagcı-Önder
The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma. Cell death & disease 10 (12) (2019)
Hilal Saraç, Tunç Morova, Elisabete Pires, James McCullagh, Anıl Kaplan, Ahmet Cingöz, Tugba Bagcı-Önder, Tamer T Önder, Akane Kawamura, Nathan A Lack
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer. Oncogene 39 (10) (2019)

Ahmet Cingöz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ahmet Cingöz